Stockscreener 앱 받기
10.10
2.02%
0.20
시간 외 거래:
9.85
-0.25
-2.48%
Biomea Fusion Inc 주식(BMEA)의 최신 뉴스
Biomea Fusion: Recent Rally May Not Last, Despite Upcoming Data Catalysts - Seeking Alpha
We're Keeping An Eye On Biomea Fusion's (NASDAQ:BMEA) Cash Burn Rate - Simply Wall St
Biomea Fusion, Inc. (NASDAQ:BMEA) to Post Q1 2025 Earnings of ($0.82) Per Share, Capital One Financial Forecasts - MarketBeat
Biomea Fusion, Inc. (NASDAQ:BMEA) to Post Q1 2025 Earnings of ($0.82) Per Share, Capital One Financial Forecasts - Defense World
BMEA Stock Up 9% as FDA Lifts Clinical Hold on 2 Diabetes Studies - MSN
Biomea Fusion Sees Unusually Large Options Volume (NASDAQ:BMEA) - MarketBeat
Biomea Fusion (NASDAQ:BMEA) Stock Rating Upgraded by RODMAN&RENSHAW - MarketBeat
Scotiabank raises Biomea Fusion target on clinical progress By Investing.com - Investing.com South Africa
Biomea Fusion stock boosted by clinical progress in diabetes treatmentTruist - Investing.com
Scotiabank raises Biomea Fusion target on clinical progress By Investing.com - Investing.com Canada
Biomea’s diabetes studies back in business as FDA lifts hold - BioWorld Online
Wall Street SWOT: Biomea Fusion stock faces hurdles amid diabetes drug setback - Investing.com
Scotiabank raises Biomea Fusion target on clinical progress - Investing.com
Piper Sandler maintains Overweight on Biomea Fusion - Investing.com
Biomea Fusion PT raised by analysts as FDA lifts clinical holds for trials - Investing.com
FDA Removes Clinical Hold On Biomea Fusion's Early-Stage Trials For Potential Diabetes Candidate - AOL
Biomea upgraded by analysts after FDA lifts clinical hold (NASDAQ:BMEA) - Seeking Alpha
FDA Removes Clinical Hold On Biomea Fusion's Early-Stage Trials For Potential Diabetes Candidate - Yahoo Finance
IonQ, Biomea Fusion, Rocket Lab USA And Other Big Stocks Moving Higher On Friday - MSN
Scotiabank raises Biomea Fusion target on clinical progress By Investing.com - Investing.com UK
Biomea Fusion (NASDAQ:BMEA) Price Target Raised to $9.00 - MarketBeat
Biomea’s stock bounces back as FDA lifts clinical hold on diabetes trials - Yahoo Finance
Biomea’s stock bounces back as FDA lifts clinical hold on diabetes trials - Pharmaceutical Technology
IonQ, Biomea Fusion, Rocket Lab USA And Other Big Stocks Moving Higher On Friday - Benzinga
BMEA Stock Up 9% as FDA Lifts Clinical Hold on 2 Diabetes Studies - Zacks Investment Research
BMEA Stock Up 9% as FDA Lifts Clinical Hold on 2 Diabetes Studies - Yahoo Finance
Biomea Fusion (NASDAQ:BMEA) Stock Rating Upgraded by Truist Financial - MarketBeat
Biomea Fusion stock boosted by clinical progress in diabetes treatmentTruist - Investing.com India
Truist Securities Upgrades Biomea Fusion (BMEA) - MSN
US FDA lifts clinical hold on Biomea's diabetes trials after safety review - Reuters
US FDA lifts clinical hold on Biomea’s diabetes trials - WIBQ
US FDA lifts clinical hold on Biomea’s diabetes trials - WSAU
US FDA lifts clinical hold on Biomea’s diabetes trials - WNWN-FM
US FDA lifts clinical hold on Biomea’s diabetes trials - WKZO
Biomea stock jumps 9% after FDA lifts hold on Phase 1/2 study (NASDAQ:BMEA) - Seeking Alpha
Biomea Fusion upgraded to Buy from Neutral at Rodman & Renshaw - TipRanks
Biomea Fusion: FDA Lifts Hold on Diabetes-Treatment Trials - MarketWatch
FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes Trials - GlobeNewswire
FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes Trials - GlobeNewswire Inc.
DRW Securities LLC Takes Position in Biomea Fusion, Inc. (NASDAQ:BMEA) - Defense World
Bank of New York Mellon Corp Buys 29,400 Shares of Biomea Fusion, Inc. (NASDAQ:BMEA) - Defense World
(BMEA) Investment Report - Stock Traders Daily
Short Interest in Biomea Fusion, Inc. (NASDAQ:BMEA) Expands By 7.8% - Defense World
Biomea Fusion, Inc. (NASDAQ:BMEA) Short Interest Update - MarketBeat
(BMEA) Investment Analysis - Stock Traders Daily
Biomea Fusion, Inc. (NASDAQ:BMEA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Biomea Fusion, Inc. (NASDAQ:BMEA) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Biomea Fusion, Inc. (NASDAQ:BMEA) Sees Large Decline in Short Interest - MarketBeat
Biomea Fusion, Inc. Expected to Post Q3 2024 Earnings of ($1.08) Per Share (NASDAQ:BMEA) - MarketBeat
Capital One Financial Comments on Biomea Fusion, Inc.’s Q3 2024 Earnings (NASDAQ:BMEA) - Defense World
iA Global Asset Management Inc. Acquires New Position in Biomea Fusion, Inc. (NASDAQ:BMEA) - Defense World
Capital One Initiates Coverage of Biomea Fusion (BMEA) with Overweight Recommendation - MSN
(BMEA) Technical Pivots with Risk Controls - Stock Traders Daily
Biomea Fusion (NASDAQ:BMEA) Now Covered by Analysts at Capital One Financial - Defense World
Biomea Fusion (NASDAQ:BMEA) Now Covered by Analysts at Capital One Financial - MarketBeat
Biomea Fusion (NASDAQ:BMEA) Price Target Lowered to $22.00 at Citigroup - Defense World
Citigroup Trims Biomea Fusion (NASDAQ:BMEA) Target Price to $22.00 - MarketBeat
Biomea Fusion price target lowered to $22 from $45 at Citi - TipRanks
SG Americas Securities LLC Buys 28,085 Shares of Biomea Fusion, Inc. (NASDAQ:BMEA) - Defense World
Following a 63% decline over last year, recent gains may please Biomea Fusion, Inc. (NASDAQ:BMEA) institutional owners - Simply Wall St
Wall Street Analysts Think Biomea Fusion (BMEA) Could Surge 317.86%: Read This Before Placing a Bet - MSN
With 51% institutional ownership, Biomea Fusion, Inc. (NASDAQ:BMEA) is a favorite amongst the big guns - Yahoo Finance
Wall Street Analysts Think Biomea Fusion (BMEA) Could Surge 317.86%: Read This Before Placing a Bet - Yahoo Finance Australia
Biomea Fusion, Inc. (NASDAQ:BMEA) Receives $28.25 Average Target Price from Brokerages - MarketBeat
0.05%
4.86%
자본화:
|
볼륨(24시간):